Anticancer activity of 4'-phenyl-2,2':6',2″-terpyridines - behind the metal complexation

Terpyridine complexes are known for their broad biological activities, of which their Anticancer potency is the most extensively studied. Strikingly, free ligand activity has rarely been described in the literature. In this study, a lipophilic derivative of terpyridine 4'-(1-decyl-2,3-triazol-4-yl)phenyl-2,2':6',2″-terpyridine (L) and its complexes were investigated to determine their mechanism of Anticancer activity. Our results show that a free ligand expresses the same level of activity on a panel of Cancer cells with a low toxicity towards normal fibroblasts as complexes with Cd, Zn or Cu. Breast Cancer (MCF-7 cell line) was the most vulnerable for the tested compounds with the IC₅₀ values in the nanomolar range (IC₅₀ = 40 nM for L.) The addition of Cu(II) ions increased its activity even further, thus suggesting that ligand exchange and ROS production are the main components of its activity. A cell cycle analysis indicated its inhibition at the G0/G1 phase and the subsequent Apoptosis as the cell death mode. A detailed analysis of the protein level that was involved in the aforementioned processes confirmed previous results. Furthermore, the Reactive Oxygen Species generation and DNA intercalation confirmed its cleaving activity.